Michael E Williams

Michael E Williams

UNVERIFIED PROFILE

Are you Michael E Williams?   Register this Author

Register author
Michael E Williams

Michael E Williams

Publications by authors named "Michael E Williams"

Are you Michael E Williams?   Register this Author

47Publications

1057Reads

45Profile Views

Risk of Major Bleeding with Ibrutinib.

Clin Lymphoma Myeloma Leuk 2018 11 1;18(11):755-761. Epub 2018 Aug 1.

Division of Hematology-Oncology, Department of Medicine and Cancer Center, University of Virginia Health System, Charlottesville, VA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S21522650183028
Publisher Site
http://dx.doi.org/10.1016/j.clml.2018.07.287DOI Listing
November 2018

Implementation of a Model-Based Design in a Phase Ib Study of Combined Targeted Agents.

Clin Cancer Res 2017 Dec 21;23(23):7158-7164. Epub 2017 Jul 21.

Division of Translational Research & Applied Statistics, Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-1069DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712236PMC
December 2017

Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research.

J Natl Cancer Inst 2016 12 16;108(12). Epub 2016 Dec 16.

Department of Medicine, Mayo Clinic, Rochester, MN (GSN); Department of Internal Medicine, Ohio State University, Columbus, OH (KAB); Department of Medicine, Oncology Division, Washington University, St. Louis, MO (BSK); Wilmot Cancer Center and Division of Hematology/Oncology, University of Rochester, Rochester, NY (JWF); Coordinating Center for Clinical Trials (LB), Division of Cancer Treatment and Diagnosis (RFL), and Center for Cancer Research (WHW), National Cancer Institute, National Institute of Health, Bethesda, MD; Division of Oncology, University of Washington, Seattle WA (DGM); British Colombia Cancer Agency, Vancouver, BC (LHS); Department of Medicine, University of Virginia, Charlottesville, VA (MEW); Department of Medicine, Weil Cornell University, New York, NY (JPL); Department of Medicine, University of Chicago, Chicago, IL (SMS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw257DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080361PMC
December 2016

Development and characterization of a Mantle Cell Lymphoma Cell Bank in the American Type Culture Collection.

Leuk Lymphoma 2015 Jul 11;56(7):2114-22. Epub 2015 Feb 11.

Department of Pathology, NYU School of Medicine , New York, NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.970548DOI Listing
July 2015

Anxiety and health-related quality of life among patients with low-tumor burden non-Hodgkin lymphoma randomly assigned to two different rituximab dosing regimens: results from ECOG trial E4402 (RESORT).

J Clin Oncol 2015 Mar 20;33(7):740-8. Epub 2015 Jan 20.

Lynne I. Wagner and David Cella, Northwestern University Feinberg School of Medicine, Chicago, IL; Fengmin Zhao, Fangxin Hong, Dana-Farber Cancer Institute, Boston, MA; Michael E. Williams, University of Virginia, Charlottesville, VA; John C. Krauss, University of Michigan, Ann Arbor, MI; Ranjana H. Advani, Stanford University, Stanford; Sandra J. Horning, Genentech, South San Francisco, CA; Ronald S. Go, Gunderson Health System, La Crosse; Brad S. Kahl, University of Wisconsin, Madison, WI; Thomas M. Habermann, Mayo Clinic, Rochester; Joseph W. Leach, Metro Minnesota Community Clinical Oncology Program, Minneapolis, MN; Brian O'Connor, Frederick Memorial Health System, Frederick, MD; Stephen J. Schuster, University of Pennsylvania, Philadelphia, PA; and Randy D. Gascoyne, British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/7/740.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.57.6801
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.57.6801DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334777PMC
March 2015

Rituximab extended schedule or re-treatment trial for low-tumor burden follicular lymphoma: eastern cooperative oncology group protocol e4402.

J Clin Oncol 2014 Oct 25;32(28):3096-102. Epub 2014 Aug 25.

Brad S. Kahl, University of Wisconsin, Madison; Christopher G. Peterson, Aspirus Regional Cancer Center, Wausau; Matthias Weiss, Marshfield Clinic, Marshfield, WI; Fangxin Hong, Dana-Farber Cancer Institute, Boston, MA; Michael E. Williams, University of Virginia, Charlottesville, VA; Randy D. Gascoyne, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Lynne I. Wagner, Northwestern University, Chicago, IL; John C. Krauss, University of Michigan, Ann Arbor, MI; Thomas M. Habermann, Mayo Clinic, Rochester; Mark D. Sborov, Fairview-Southdale Hospital, St Louis Park, MN; Lode J. Swinnen, Johns Hopkins University, Baltimore, MD; Stephen J. Schuster, University of Pennsylvania, Philadelphia; W. Christopher Ehmann, Penn State Cancer Institute, Hershey, PA; S. Eric Martin, Christiana Care Community Clinical Oncology Program and Helen F. Graham Cancer Network, Newark, DE; and Sandra J. Horning, Genentech, South San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.5853DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171355PMC
October 2014

Transplantation for mantle cell lymphoma: is it the right thing to do?

Hematology Am Soc Hematol Educ Program 2013 ;2013:568-74

1Hematology/Oncology Division and Cancer Center, University of Virginia Health System, Charlottesville, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2013.1.568DOI Listing
July 2014

Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.

J Clin Oncol 2013 Oct 3;31(29):3688-95. Epub 2013 Sep 3.

Andre Goy, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack; Lei Zhang, Sherri Cicero, and Tommy Fu, Celgene, Summit, NJ; Rajni Sinha, Emory University Winship Cancer Institute, Atlanta, GA; Michael E. Williams, University of Virginia Health System, Charlottesville, VA; Sevgi Kalayoglu Besisik, Istanbul University Faculty of Medicine, Istanbul, Turkey; Johannes Drach, Medical University of Vienna, Vienna, Austria; Radhakrishnan Ramchandren, Karmanos Cancer Institute, Detroit, MI; and Thomas E. Witzig, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.2835DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879693PMC
October 2013

Recent advances in mantle cell lymphoma: report of the 2012 Mantle Cell Lymphoma Consortium Workshop.

Leuk Lymphoma 2013 Sep 4;54(9):1882-90. Epub 2013 Mar 4.

University of Virginia Health System, Charlottesville, VA, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3109/10428194.2013.77
Publisher Site
http://dx.doi.org/10.3109/10428194.2013.771400DOI Listing
September 2013

Current and emerging therapies in mantle cell lymphoma.

Curr Treat Options Oncol 2013 Jun;14(2):198-211

Hematology/Oncology Division, University of Virginia Health System, Hospital West, Room 6023, Jefferson Park Avenue, Charlottesville, VA 22908, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-013-0230-zDOI Listing
June 2013

Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop.

Leuk Lymphoma 2011 Jan 6;52(1):24-33. Epub 2010 Dec 6.

University of Virginia School of Medicine, Charlottesville, VA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2010.532893DOI Listing
January 2011

Exposure assessment among US workers employed in semiconductor wafer fabrication.

J Occup Environ Med 2010 Nov;52(11):1075-81

Vanderbilt University Department of Medicine and Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JOM.0b013e3181f6ee1dDOI Listing
November 2010

Management of mantle cell lymphoma: key challenges and next steps.

Clin Lymphoma Myeloma Leuk 2010 Oct;10(5):336-46

University of Virginia School of Medicine, Charlottesville, VA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLML.2010.n.066DOI Listing
October 2010

Recent advances in the treatment of mantle cell lymphoma: a post-ASH 2009 discussion.

Clin Adv Hematol Oncol 2010 Apr;8(4):A1-14; quiz A15

Lymphoma/Myeloma Service and Lymphoma Translational Research Laboratory, Roswell Park Cancer Institute, Buffalo, New York, USA.

View Article

Download full-text PDF

Source
April 2010

Clinical roundtable monograph: Recent advances in the treatment of mantle cell lymphoma: a post-ASH 2009 discussion.

Clin Adv Hematol Oncol 2010 Apr;8(4 Suppl 8):1-14; quiz 2p following page 14

Lymphoma/Myeloma Service, Lymphoma Translational Research Laboratory, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
April 2010

Mantle cell lymphoma: report of the 2009 Mantle Cell Lymphoma Consortium Workshop.

Leuk Lymphoma 2010 Mar;51(3):390-8

Hematology/Oncology Division and Cancer Center, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428190903503453DOI Listing
March 2010

Mantle cell lymphoma: biological insights and treatment advances.

Clin Lymphoma Myeloma 2009 Aug;9(4):267-77

Center for Lymphoma and Myeloma, Clinical Research, Division of Hematology/Oncology, New York Weill Cornell Medical Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLM.2009.n.055DOI Listing
August 2009

Treatment strategies for relapsed and refractory aggressive non-Hodgkin's lymphoma.

Expert Opin Pharmacother 2009 Apr;10(6):983-95

University of Virginia School of Medicine, The Hematologic Malignancies Program, Cancer Center, Hematology/Oncology Division, Department of Medicine, Charlottesville, VA 22908, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656560902895715DOI Listing
April 2009

Rituximab-CD20 complexes are shaved from Z138 mantle cell lymphoma cells in intravenous and subcutaneous SCID mouse models.

J Immunol 2007 Sep;179(6):4263-71

Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.179.6.4263DOI Listing
September 2007

Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia.

J Immunol 2006 Nov;177(10):7435-43

Hematology/Oncology Division and Hematologic Malignancy Program, University of Virginia Health System, Charlottesville, VA 22908-0733, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.177.10.7435DOI Listing
November 2006

Hematologic disorders in critically ill patients.

Semin Respir Crit Care Med 2006 Jun;27(3):286-96

Division of Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA.

View Article

Download full-text PDF

Source
https://www.thieme-connect.com/products/ejournals/pdf/10.105
Web Search
http://dx.doi.org/10.1055/s-2006-945529DOI Listing
June 2006

Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma.

Leuk Res 2006 Apr 23;30(4):449-57. Epub 2005 Sep 23.

The Department of Advanced Therapeutics, BC Cancer Research Center, 675 West 10th Avenue, 5th Floor, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2005.08.016DOI Listing
April 2006

The shaving reaction: rituximab/CD20 complexes are removed from mantle cell lymphoma and chronic lymphocytic leukemia cells by THP-1 monocytes.

J Immunol 2006 Feb;176(4):2600-9

Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.

View Article

Download full-text PDF

Source
http://www.jimmunol.org/content/176/4/2600.full.pdf
Web Search
http://dx.doi.org/10.4049/jimmunol.176.4.2600DOI Listing
February 2006

Biology and therapy of mantle cell lymphoma.

Curr Opin Oncol 2005 Sep;17(5):425-31

Hematology/Oncology Division and Cancer Center and the Hematologic Malignancy Program, University of Virginia Health System, Jefferson Park Avenue, Charlottesville, VA 22908, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.cco.0000174039.69656.2bDOI Listing
September 2005

Complement activation and C3b deposition on rituximab-opsonized cells substantially blocks binding of phycoerythrin-labeled anti-mouse IgG probes to rituximab.

J Immunol Methods 2004 Nov;294(1-2):37-42

Department of Biochemistry and Molecular Genetics, University of Virginia Health Science Center, Charlottesville, VA 22908-0733, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2004.08.004DOI Listing
November 2004

Rituximab infusion promotes rapid complement depletion and acute CD20 loss in chronic lymphocytic leukemia.

J Immunol 2004 Mar;172(5):3280-8

Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.172.5.3280DOI Listing
March 2004

New therapies for mantle cell lyphoma.

Clin Adv Hematol Oncol 2003 Dec;1(12):708, 11

University of Virginia Health System, VA, USA.

View Article

Download full-text PDF

Source
December 2003

Mantle cell lymphoma.

Curr Treat Options Oncol 2003 Aug;4(4):281-7

Division of Hematology/Oncology, University of Virginia Health System, Box 800716, Charlottesville, VA 22908, USA.

View Article

Download full-text PDF

Source
August 2003

Testicular lymphoma: a literature review and report of a case with a zoster-like cutaneous recurrence.

Clin Lymphoma 2002 Mar;2(4):238-41

Division of Hematology/Oncology and Adult Stem Cell Transplantation Program, University of Virginia Health System, Charlottesville, VA 22908, USA.

View Article

Download full-text PDF

Source
March 2002

From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades.

Hum Pathol 2002 Jan;33(1):7-20

Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/hupa.2002.30221DOI Listing
January 2002